WATCH: Drug companies ‘bear none of the consequences’ of skyrocketing prices, Sen. Wyden says
The hearing marks the first time lawmakers have called top industry executives to account for rising prices that are squeezing Americans.
House Democrats announce they are investigating drug pricing
House Democrats announced a sweeping investigation Monday of the pharmaceutical industry's pricing practices, jockeying for the upper hand with the Trump administration on an issue that concerns Americans across the political spectrum.
Watch 11:08
Do prescription drug middlemen help keep prices high?
Americans pay more for prescription drugs than any country in the world, and the pharmaceutical industry earns billions in profits each year. Critics blame pharmacy benefit managers, or PBMs, for a portion of those high costs through their role as…
Justice Department announces crackdown on fraudulent opioid prescriptions
Federal agencies on Thursday announced charges in what Attorney General Jeff Sessions called “the largest health care fraud takedown in American history,” an investigation into over $2 billion in alleged fraud by doctors, pharmacists, and nurses.
Rushing to judgment is misguided. There are no quick fixes here, and while the Trump proposals are viewed as fatally flawed by many experts, they also include some worthy ideas.
The cost of insulin medications has steadily risen over the past decade by nearly 300 percent.
More than 1,300 lobbyists roamed the halls of Congress on the 21st Century Cures Act, and disclosure reports show most of them were working for pharmaceutical companies.
The superbug is a reminder of the unintended consequences of the modern quest for productivity. Barring a solution, it will take an enormous toll.
The absence of drug-pricing proposals from the GOP contenders illustrates how hard it would be for Sanders or Clinton to get Congressional approval should they win office.
